ATE103294T1 - Peptidfragmente von hiv. - Google Patents
Peptidfragmente von hiv.Info
- Publication number
- ATE103294T1 ATE103294T1 AT90308662T AT90308662T ATE103294T1 AT E103294 T1 ATE103294 T1 AT E103294T1 AT 90308662 T AT90308662 T AT 90308662T AT 90308662 T AT90308662 T AT 90308662T AT E103294 T1 ATE103294 T1 AT E103294T1
- Authority
- AT
- Austria
- Prior art keywords
- proline
- hiv
- peptide
- isoleucine
- fragment
- Prior art date
Links
- 108010033276 Peptide Fragments Proteins 0.000 title 1
- 102000007079 Peptide Fragments Human genes 0.000 title 1
- 208000030507 AIDS Diseases 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 235000018417 cysteine Nutrition 0.000 abstract 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 239000004474 valine Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898918200A GB8918200D0 (en) | 1989-08-09 | 1989-08-09 | The peptide fragments of hiv |
EP90308662A EP0412766B1 (de) | 1989-08-09 | 1990-08-07 | Peptidfragmente von HIV |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE103294T1 true ATE103294T1 (de) | 1994-04-15 |
Family
ID=43806939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT90308662T ATE103294T1 (de) | 1989-08-09 | 1990-08-07 | Peptidfragmente von hiv. |
Country Status (12)
Country | Link |
---|---|
US (1) | US5700635A (de) |
EP (1) | EP0412766B1 (de) |
JP (1) | JPH04507100A (de) |
AT (1) | ATE103294T1 (de) |
CA (1) | CA2064691A1 (de) |
DE (1) | DE69007571T2 (de) |
DK (1) | DK0412766T3 (de) |
ES (1) | ES2054256T3 (de) |
GB (2) | GB8918200D0 (de) |
HK (1) | HK141494A (de) |
SG (1) | SG130094G (de) |
WO (1) | WO1991001996A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5128319A (en) | 1987-08-28 | 1992-07-07 | Board Of Regents, The University Of Texas System | Prophylaxis and therapy of acquired immunodeficiency syndrome |
US6210873B1 (en) | 1987-08-28 | 2001-04-03 | Board Of Regents, The University Of Texas System | Methods and compositions for the priming of specific cytotoxic T-lymphocyte response |
EP0346022B1 (de) * | 1988-06-10 | 1996-02-14 | United Biomedical, Inc. | Peptidfragmente von HIV |
US5480967A (en) * | 1990-01-05 | 1996-01-02 | United Biomedical, Inc. | HIV-1 core protein fragments |
US5603933A (en) * | 1993-08-31 | 1997-02-18 | Board Of Regents, The University Of Texas | CD4 peptides for binding to viral envelope proteins |
CA2173138A1 (en) * | 1993-10-19 | 1995-04-27 | Masafumi Takiguchi | Peptide capable of inducing immune response against hiv and aids preventive or remedy containing the peptide |
GB9426153D0 (en) * | 1994-12-23 | 1995-02-22 | Medical Res Council | Improvements in or relating to vaccines |
ES2341429T3 (es) * | 1999-12-23 | 2010-06-21 | Medical Research Council | Mejoras en las respuestas inmunitarias al vih o relacionadas con las mismas. |
CU23235A1 (es) * | 2001-02-28 | 2007-09-26 | Ct Ingenieria Genetica Biotech | POXVIRUS RECOMBINANTES PARA PROTEINAS QUIMéRICAS DEL VIRUS DE LA INMUNODEFICIENCIA HUMANA Y SU APLICACION EN LA TERAPéUTICA Y LA PREVENCION DEL SIDA |
NZ588445A (en) * | 2008-04-24 | 2013-03-28 | Avery Dennison Corp | Sheet having labels with adhesive removable from liner with weakened line on liner having linear portions and apices so as to fold about linear portions |
EP2620446A1 (de) | 2012-01-27 | 2013-07-31 | Laboratorios Del Dr. Esteve, S.A. | Immunogene zur HIV-Impfung |
CA3161633A1 (en) | 2019-11-14 | 2021-05-20 | Aelix Therapeutics, S.L. | Dosage regimens for vaccines |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62164696A (ja) * | 1986-01-06 | 1987-07-21 | エフ.ホフマン ― ラ ロシュ アーゲー | HTLV−3gag遺伝子の発現 |
NO881151L (no) * | 1987-03-27 | 1988-09-28 | Syntello Ab | Syntetisk hiv-1-antigen. |
EP0330359A3 (de) * | 1988-02-25 | 1991-06-05 | Bio-Rad Laboratories, Inc. | Zusammensetzung, verwendbar zur Diagnose und Behandlung von HIV-I-Infektion |
-
1989
- 1989-08-09 GB GB898918200A patent/GB8918200D0/en active Pending
-
1990
- 1990-08-07 CA CA002064691A patent/CA2064691A1/en not_active Abandoned
- 1990-08-07 DK DK90308662.7T patent/DK0412766T3/da active
- 1990-08-07 GB GB9201468A patent/GB2250994B/en not_active Expired - Fee Related
- 1990-08-07 DE DE69007571T patent/DE69007571T2/de not_active Revoked
- 1990-08-07 WO PCT/GB1990/001230 patent/WO1991001996A1/en active Application Filing
- 1990-08-07 JP JP2511801A patent/JPH04507100A/ja active Pending
- 1990-08-07 AT AT90308662T patent/ATE103294T1/de not_active IP Right Cessation
- 1990-08-07 EP EP90308662A patent/EP0412766B1/de not_active Revoked
- 1990-08-07 ES ES90308662T patent/ES2054256T3/es not_active Expired - Lifetime
-
1994
- 1994-09-06 SG SG130094A patent/SG130094G/en unknown
- 1994-12-15 HK HK141494A patent/HK141494A/xx not_active IP Right Cessation
- 1994-12-19 US US08/359,000 patent/US5700635A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DK0412766T3 (da) | 1994-07-18 |
JPH04507100A (ja) | 1992-12-10 |
DE69007571T2 (de) | 1994-09-08 |
HK141494A (en) | 1994-12-23 |
GB9201468D0 (en) | 1992-04-01 |
EP0412766A1 (de) | 1991-02-13 |
CA2064691A1 (en) | 1991-02-10 |
GB2250994A (en) | 1992-06-24 |
GB8918200D0 (en) | 1989-09-20 |
GB2250994B (en) | 1993-08-25 |
EP0412766B1 (de) | 1994-03-23 |
ES2054256T3 (es) | 1994-08-01 |
US5700635A (en) | 1997-12-23 |
WO1991001996A1 (en) | 1991-02-21 |
DE69007571D1 (de) | 1994-04-28 |
SG130094G (en) | 1995-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2255093A (en) | Hiv-1 core protein fragments | |
ATE373010T1 (de) | Gag-antigen und dessen verwendung zum nachweis von lav-infektion, sowie in immunogenen zusammensetzungen | |
ATE127345T1 (de) | Stressproteine und verwendungen dafür. | |
ATE188612T1 (de) | Konjugate von schwach immunogenen antigenen und synthetischen peptidträgern und impfstoffe diese enthaltend | |
DE68925660T2 (de) | Peptidfragmente von HIV | |
ATE103294T1 (de) | Peptidfragmente von hiv. | |
ATE185148T1 (de) | Lipopeptide, t-cytotoxische lymphocyte aktivierend, und deren verwendung als vakzine | |
EA200100395A1 (ru) | Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием | |
ES2071038T3 (es) | Peptidos asociados al hiv. | |
NZ224251A (en) | Synthetic rhinovirus (hrv) peptides and vaccines | |
ATE111485T1 (de) | Peptidbehandlung von hartnäckigen infektionskrankheiten. | |
ES2061944T3 (es) | Conjugado de peptido inmunologicamente activo ppd (nanp)n util como vacuna antimalaria. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EEIH | Change in the person of patent owner | ||
REN | Ceased due to non-payment of the annual fee | ||
RZN | Patent revoked |